Interfering in private contracts between pharmacy benefit managers and their customers will drive drug costs up, not down.
Public Favors Government Drug Negotiations, Until They Learn What It Really Means
Senate Democrats are preparing to move a $3.5 trillion “human infrastructure” bill, but have to find ways to offset the cost.
No Government Price Controls to Pay for Biden’s Gargantuan Spending Bill
Sen. Ron Wyden (D-Ore.) wants to use price controls in Medicare Part D to pay for President Biden’s extravagant spending.
Democrats in Congress Move Country Closer to Bankruptcy
Democrats want to pass a $4.1 trillion budget, massively expands social welfare programs.
President Biden’s Executive Order Will Harm Rather than Promote Competition
President Biden’s Executive Order will harm competition and increase the size, scope, and power of the federal government.
No Surprises Act Gets its First Interim Rule
The No Surprises Act was passed last year to stop surprise medical bills but in reality the law will end up causing more problems.
Biden Administration Revokes Work Incentives for Medicaid
The Biden administration continues its onslaught against innovative and effective Trump administration policies.
Obamacare Survives Third Court Challenge
The Supreme Court tossed out ObamaCare lawsuit, California et al v. Texas, stating the plaintiffs have no standing.
Canadian Drug Importation Continues to Face Obstacles
HHS asks court to dismiss PhRMA lawsuit on Canadian drug importation, stating they have no standing.
Lack of Trust in Public Health Authorities Will Impact Debate on Medicare for All
The U.S. public health system has a trust problem due to their handling of COVID-19.